ArticleApplied biochemistry and biotechnology2026
Repurposing Lapatinib and Tucatinib as Dual Inhibitors of Bcl-2 and TYMS in Breast Cancer: Insights from Transcriptomic, Computational and Cellular Assays.
Mehreen Aftab et al.PubMed ↗Publisher ↗
No numbers read from the abstract.